Company Filing History:
Years Active: 2009-2016
Title: Tomislav Dobric: Innovator in Tumor Therapeutics
Introduction
Tomislav Dobric is a prominent inventor based in Berlin, Germany. He has made significant contributions to the field of tumor therapeutics, focusing on innovative vaccine development. With a total of 2 patents, his work is paving the way for new treatment options for tumor diseases.
Latest Patents
Dobric's latest patents include groundbreaking inventions such as an allogeneic tumor therapeutic agent and a vaccine utilizing allogeneic tumor cells for the therapeutic treatment of tumor diseases. These patents detail methods for creating vaccines based on transfected human tumor cells, which have been modified ex vivo with expression constructs encoding cytokines and co-stimulatory factors. This innovative approach aims to enhance the efficacy of tumor treatments.
Career Highlights
Tomislav Dobric is currently associated with Mologen AG, a company dedicated to advancing medical therapies. His work at Mologen AG has been instrumental in developing novel therapeutic strategies for cancer treatment. His expertise in the field has positioned him as a key figure in the ongoing research and development of tumor vaccines.
Collaborations
Throughout his career, Dobric has collaborated with notable colleagues, including Burghardt Wittig and Manuel Schmidt. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas in the pursuit of effective cancer therapies.
Conclusion
Tomislav Dobric's contributions to the field of tumor therapeutics through his patents and work at Mologen AG highlight his commitment to advancing cancer treatment. His innovative approaches are set to make a significant impact on the future of medical therapies for tumor diseases.